Similar articles

• Thrombolysis in acute myocardial infarction.

  Anderson HV, Willerson JT. Anderson HV, et al. N Engl J Med. 1993 Sep 2;329(10):703-9. doi: 10.1056/NEJM199309023291006. N Engl J Med. 1993. PMID: 8345856 Review. No abstract available.
• Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group).

  Cohen M, Adams PC, Hawkins L, Bach M, Fuster V. Cohen M, et al. Am J Cardiol. 1990 Dec 1;66(19):1287-92. doi: 10.1016/0002-9149(90)91155-y. Am J Cardiol. 1990. PMID: 2244556 Clinical Trial.
• Early intravenous beta-blocker combined with thrombolytic therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI-2) Trial.

  Borzak S, Gheorghiade M. Borzak S, et al. Prog Cardiovasc Dis. 1993 Nov-Dec;36(3):261-6. doi: 10.1016/0033-0620(93)90018-9. Prog Cardiovasc Dis. 1993. PMID: 8234778 Clinical Trial. No abstract available.
• Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?

  Ridker PM, Hebert PR, Fuster V, Hennekens CH. Ridker PM, et al. Lancet. 1993 Jun 19;341(8860):1574-7. doi: 10.1016/0140-6736(93)90707-n. Lancet. 1993. PMID: 8099650 Review. No abstract available.
• Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction.

  Metz BK, Topol EJ. Metz BK, et al. Biomed Pharmacother. 1996;50(6-7):243-53. doi: 10.1016/0753-3322(96)84821-9. Biomed Pharmacother. 1996. PMID: 8952863 Review.